Artificial intelligence for digital breast tomosynthesis: Impact on diagnostic performance, reading times, and workload in the era of personalized screening

The ultimate goals of the application of artificial intelligence (AI) to digital breast tomosynthesis (DBT) are the reduction of reading times, the increase of diagnostic performance, and the reduction of interval cancer rates. In this review, after outlining the journey from computer-aided detection/diagnosis systems to AI applied to digital mammography (DM), we summarize the results of studies where AI was applied to DBT, noting that long-term advantages of DBT screening and its crucial ability to decrease the interval cancer rate are still under scrutiny. AI has shown the capability to overcome some shortcomings of DBT in the screening setting by improving diag-nostic performance and by reducing recall rates (from-2 % to-27 %) and reading times (up to-53 %, with an average 20 % reduction), but the ability of AI to reduce interval cancer rates has not yet been clearly investi-gated. Prospective validation is needed to assess the cost-effectiveness and real-world impact of AI models assisting DBT interpretation, especially in large-scale studies with low breast cancer prevalence. Finally, we focus on the incoming era of personalized and risk-stratified screening that will first see the application of contrast -enhanced breast imaging to screen women with extremely dense breasts. As the diagnostic advantage of DBT over DM was concentrated in this category, we try to understand if the application of AI to DM in the remaining cohorts of women with heterogeneously dense or non-dense breast could close the gap in diagnostic performance between DM and DBT, thus neutralizing the usefulness of AI application to DBT.

Automated summary

The ultimate goals of applying artificial intelligence (AI) to digital breast tomosynthesis (DBT) are to reduce reading times, improve diagnostic performance, and decrease interval cancer rates. While AI has shown promising results in improving DBT screening by enhancing diagnostic performance and reducing recall rates and reading times, its ability to reduce interval cancer rates still needs further investigation. Prospective validation studies are needed to assess the cost-effectiveness and real-world impact of AI models assisting DBT interpretation.